Follicle-stimulating hormone (FSH; follitropin) is a pituitary glycoprotein composed of two posttranslationally modified subunits, which must properly assemble to be biologically active. FSH has been difficult to purify and to obtain in quantities sufficient for detailed biochemical studies. We have targeted FSH expression to the mammary gland of transgenic mice by using cDNAs encoding the bovine a and FSHP subunits and a modified rat f-casein gene-based expression system. Lines of bigenic mice expressing both subunits have been generated either by coinection of the subunit transgenes or by mating mice that acquired and expressed transgenes encoding an individual subunit. Up to 60 international units (15 ,sg) of biologically active FSH per ml was detected in the milk of the bigenic mice. These lines provide a model system for studying the post-transcriptional mechanisms that effect the expression and secretion of this heterodimeric hormone.
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Follicle-stimulating hormone (FSH; follitropin) is a member of the glycoprotein family of pituitary hormones, which includes thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and chorionic gonadotropin (CG) . Like LH and CG, FSH is a gonadotropin and is composed of a common a subunit that is noncovalently linked to a hormone-specific P subunit (1, 2) . FSH has been difficult to purify and to obtain in sufficient quantities for detailed biochemical studies (for a review, see ref. 3 ). The a and FSHI subunits are posttranslationally modified, and the nature and extent of such modifications can exert a profound effect on subunit assembly, secretion, and stability (4) (5) (6) . Only heterodimers with appropriately glycosylated subunits exhibit significant biological and receptor-binding activity (5, 7, 8) . Targeting FSH to the mammary gland of transgenic animals would, therefore, serve as a model system in which to study glycoprotein processing and secretion as well as a means to produce large quantities of FSH. A standardized source of recombinant FSH would be useful to both human and livestock fertilization programs to achieve the reproducible development of ovarian follicles.
Several different milk protein-based constructs have been employed to express diverse heterologous proteins in the milk of a variety of transgenic animals (for reviews, see refs. [9] [10] [11] . We have demonstrated previously that a -524/+490 minimal rat f3-casein promoter fragment can direct the expression of chloramphenicol acetyltransferase to the mammary gland (12) . To determine whether the mammary gland could be used to secrete large quantities of a bioactive heterodimeric protein into milk, we have used a modified rat ,8-casein-based vector to target and express bovine FSH (bFSH) to the mammary gland and into the milk of transgenic mice.
MATERIALS AND METHODS
Construction of the Transgenes. The FSH subunit cDNAs were obtained from Genzyme; a as a 730-base-pair (bp) EcoRI fragment and FSH(3 as a 560-bp EcoRI/BamHI fragment. The cDNA fragments were inserted into pUC19 (13) with the rat 13-casein -524/+490 fragment (12) "To whom reprint requests should be addressed.
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Characterization of FSH in Mouse Milk. A heterologous double-antibody radioimmunoassay (RIA) was performed as described (16 For radioreceptor assays, samples were initially diluted with an equal volume of assay buffer (100 mM TrisHCl/100 mM sucrose/5 mM MgCl2/0.1% bovine serum albumin, pH 7.4) and incubated with a chicken testis receptor preparation (17) . The standard was NIH-FSH-S9 (18 (5, 21) .
RESULTS AND DISCUSSION
Characterization of the a and FSHl Transgenes. The cDNAs encoding a or FSH8 were placed into a rat f3-casein expression vector (Fig. 1) . Lines of transgenic mice were generated by either individual or coinjection (12, 22 ) of a and FSHI3 constructs. A construct carrying four copies of a GRE from the mouse mammary tumor virus promoter (Fig. 1B) was also employed to direct high-level a-subunit expression, since in the normal pituitary a is expressed in excess over the dimeric hormone (23) (24) (25) (26) (27) . Screening by PCR identified founder animals carrying either the a or the FSHB construct or both ( Fig. 1 D and E) .
Southern blot experiments were used to characterize the architecture of the integrated transgenes. Since the transgenes carry a single EcoRI site, the detection of strongly hybridizing species in the 2-to 3-kb range ( Fig. 2 A and B (Fig. 2 A and B, lane 1) ]. Some head-to-head and tail-to-tail cointegration events occurred. Divergent PCR confirmed the head-to-tail orientation (Fig. 2C) (Fig. 1 D and E), which expressed both independent loci (Fig. 3) .
Secretion of rbFSH Into Mouse Milk. rbFSH was detected in milk collected at lactation (Fig. 4A) The species of FSH present in milk were further characterized by immunoblotting (Fig. 4B) . Preparations ofpituitary oFSH (lanes B, C, and D in Fig. 4B ) and rbFSH prepared from transfected CHO cells (lane I in Fig. 4B) were included as controls. The antiserum to oFSH detected a species of 38 kDa in the milk from bigenic mouse 8942 (lanes E and K in Fig. 4B ). The 38-kDa species corresponds in size to the species detected in both the oFSH and rbFSH standards. Some microheterogeneity in the post-translational modifications of the FSH may explain the broad bands observed (see chromatofocusing results) (32, 33 I), reflecting that the antiserum was raised against oFSH rather than bESH.
A strongly immunoreactive species with a mass of 18 kDa was detected in the milk from bigenic mice, as well as from mice expressing only the a-subunit mRNA and may be free a subunit. This was not detected in the control milk sample. The immunoblot and RIA results suggest the polyclonal anti-oFSH antiserum can crossreact with both heterodimer and free a subunit, and it may contain species recognizing free bovine a and heterodimer, but with different affinities. Therefore, the immunoblot could not be used to quantitatively determine the relative abundance of a and rbFSH.
Steady-state a and FSH.3 mRNAs were quantitated by slot blot hybridization analysis. Summarized in Table 1 , a mRNA levels were consistently higher, 7-to 17-fold, than those for FSHf3 mRNA. Levels of both mRNAs were independent of transgene copy number; line 7905 carries a single GREa transgene yet expresses high levels of a mRNA. Consistent with previous results, expression appeared to be highly dependent on the site of integration (11, 12, 31) , and the level of mRNA was observed to vary as much as 3-fold between littermates (e.g., a-FSH mRNA, line 7919). The relatively high a and low FSH/3 mRNA levels suggest that posttranscriptional mechanisms influence their steady-state levels, supporting the hypothesis that the 3' untranslated region of FSH.8 mRNA may impart instability (34) .
Milk of bigenic mouse 8942 was capable of displacing an 125I-labeled purified porcine FSH preparation from chicken testis FSH receptors (Fig. 4C) (2, 17) . No These results, summarized in To measuie the biological activity of the rbFSH, rat granulosa cell in vitro bioassays were utilized (Fig. 4D) terminal sialic acid residues to these proteins. The lack of terminal sialic acid residues does not affect FSH receptor binding or in vitro bioactivity but may, however, be related to enhanced clearance rates for FSH in blood plasma (5, 32) .
By several independent criteria we have demonstrated that rbFSH can be produced in transgenic mice using a rat The lines of mice bearing the individual a, and FSHo3 transgenes provide useful models for the study of the mechanisms regulating the post-translational processing of both the individual subunits and the heterodimer. Finally, these studies have demonstrated that the mammary gland can be used as a bioreactor to direct the high expression and vectoral secretion into milk of heterodimeric proteins requiring extensive post-translational modifications. Although the quantities ofglycosylated hormone produced in mice are sufficient for further biochemical analysis, the introduction of such transgenes into livestock (9) will be required to provide sufficient quantities for both research and commercial purposes.
